CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
AI scientist and Google researcher Ray Kurzweil joins BCI startup Subsense, which develops non-surgical BCI tech involving inhaled nanoparticles, as an advisor

From Fortune

By Alexei Oreskovic

September 3, 2026

AI scientist and Google researcher Ray Kurzweil joins BCI startup Subsense, which develops non-surgical BCI tech involving inhaled nanoparticles, as an advisor

AI scientist and Google researcher Ray Kurzweil joins BCI startup Subsense, which develops non-surgical BCI tech involving inhaled nanoparticles, as an advisor

Ray Kurzweil, the pioneering AI scientist, Google researcher, and “AI visionary,” is joining a Silicon Valley startup developing a method to put computers in the brain by snorting nanoparticles. 

Subsense, a four-year old company developing brain-computer interface technology, announced the news alongside Kurzweil at an event at its Palo Alto headquarters on Wednesday evening. 

“Ultimately, we want to merge [the smartphone] with the brain,” said Kurzweil, whose famous “singularity” theory posits that technology will soon allow humans to transcend the limitations of our biological brains.  

“The whole point of humans is to go to greater frontiers, expand who we are,” Kurzweil said at the event. He described external devices like smartphones as a barrier that slows down our ability to access the power of AI.

Subsense is one of numerous neurotechnology companies developing brain computing interfaces, with Elon Musk’s Neuralink most prominent in the group. Neuralink has implanted wireless chips in the brains of roughly a dozen people, enabling patients paralyzed by spinal cord injuries to control computers with their thoughts. 

While Neuralink requires drilling through the skull to implant electrodes, Subsense is developing a nonsurgical—though still quite invasive—approach that involves introducing charged nanoparticles into the brain intranasally. The process would be similar to inhaling allergy medicine via a nasal spray. Once inside the brain, the nanoparticles would be controlled—to stimulate neurons in specific areas of the brain or to read neuron activity—through a specialized cap or headset containing magnetic coils. Subsense showed off a nonfunctional mock-up of a cap that looked like a cross between a baseball cap and a bike helmet.

But the sci-fi-like technology is years away from being available, assuming it ever makes it beyond the lab. Subsense, which has raised $27 million in funding, is currently doing preclinical work, experimenting with various elements of the technology and conducting some experiments on mice. Subsense hopes to then make the technology available for medical use, and eventually make it a consumer product. 

“I believe the brain-computer interface eventually may become one of the most intimate technologies that human beings ever created,” CEO Tetiana Aleksandrova said on Wednesday. 

As a product and vision advisor at Subsense, Kurzweil will provide perspective on the company’s technology road map and on how the convergence of AI and neural interfaces will reshape human-computer interactions, the company said. Kurzweil, a National Medal of Technology and Innovation recipient, is one of the most influential thinkers in the field of artificial intelligence, with books such as The Age of Intelligent Machines and The Singularity Is Near predicting many of today’s technologies.

View original article on fortune.com

Most Recent

Startup Abby Care raises $82 million to turn family members into paid caregivers

As a kid, Havi Nguyen sometimes missed school to translate at doctor's appointments, and was managing Medicaid paperwork for her family, who had recently immigrated from Vietnam.

Oct 18, 2026

795 accounts funded by ADI Predictstreet's own fee-collecting wallet drove 99% of the FIFA-partnered prediction market's activity since late August

ADI Predictstreet, backed by Abu Dhabi's royal family, paid close to $150 million for advertising rights during the World Cup

Oct 18, 2026

World launches World ID suite for banks, makes Zoom deepfake check generally available

The identity project co-founded by OpenAI CEO Sam Altman named Bain Capital and VanEck Funds among its design partners but did not name a bank that has started using the product.

Oct 18, 2026

Exclusive: Stand raises $70 million at $1 billion valuation to price wildfire risk by treating homes like airplanes in flight

Matt DiStefano shares his screen and rotates a gray 3D model of a California neighborhood. He zooms in on one house and overlays a heat map.

Oct 18, 2026

Similar Posts

Companies developing brain-computer interfaces have already raised more than $1B in 2026, compared with $1.56B in the previous four years combined

PitchBook: companies developing brain-computer interfaces have already raised more than $1B in 2026, compared with $1.56B in the previous four years combined — Start-ups developing thought-controlled technology are drawing venture capital funding from Silicon Valley to Beijing.

Sep 16, 2026

Omi, a competitor to Friend, wants to boost your productivity using AI and a ‘brain interface’

San Francisco startup Based Hardware announced during the Consumer Electronics Show in Las Vegas this week the launch of a new AI wearable, Omi, to boost productivity. The device can be worn as a necklace where Omi’s AI assistant can be activated by saying “Hey Omi.” The startup also claims Omi can be attached to the side of your head, using medical tape, using a “brain interface” to understand when you’re talking to it. The startup’s founder, Nik Shevchenko, started marketing this device on Ki

Jan 8, 2025

BCI startup Neurable looks to license its ‘mind-reading’ tech for consumer wearables

The startup specializes in "non-invasive" "mind-reading" tech — a kind of neural data collection that, its CEO hopes, will have all sorts of consumer applications.

Apr 28, 2026

GPT-6 Astra and the Fourth Exponential

AI computer tool use is a big deal.

Sep 7, 2026